A novel approach for examining the anti-proliferative effect of protein kinase C inhibitors against human astrocytoma cells

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 685-692

  Sharif, Taraneh R ^a   Sharif, Mohammed ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Astrocytoma cell line; Cell growth; Elk1; GAL4; Luciferase; Mitogen activated protein (MAP) kinase; Mitogens; Protein kinase C; Protein kinase C inhibitors; U 373MG

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTINEOPLASTIC AGENT; MIDOSTAURIN; PROTEIN KINASE INHIBITOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031667867     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.685     Document Type: Article

References (31)

1. Sharif M: Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines. Int J Oncol 12: 273-286, 1998.
2. Kleihues P, Burger PC and Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3: 255-268, 1993.
3. S6K) in human astrocytoma cells. Int J Oncol 11: 797-805, 1997.
4. Luo W, Sharif TR, Houghton PJ and Sharif M: CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein (MAP) kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Cell Growth Differ 8: 1225-1240, 1997.
5. Fuller GN and Bigner SH: Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276: 299-306, 1992.
6. Luo W, Sharif TR and Sharif M: Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56: 4983-4991, 1996.
7. Sharif TR, Luo W, Houghton PJ and Sharif M: Substance K peptide induces mitogenesis by activating the mitogen-activated protein kinase signaling pathway through the substance P receptor (NK-1 subtype) in human astrocytoma cells. Cell Pharmacol 3: 441-449, 1996.
8. Sharif TR, Luo W and Sharif M: Functional expression of bombesin receptor in most adult and pediatrie human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Mol Cell Endocrinol 130: 119-130, 1997.
9. Ziehe M, Morbidelli L, Pacini M, Geppetti P, Alessandri G and Maggi CA: Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40: 264-278, 1990.
10. Otsuka M and Yoshioka K: Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73: 229-308, 1993.
11. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
12. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
13. Cowley S, Paterson H, Kemp P and Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
14. Hunter T: Oncoprotein networks. Cell 88: 333-346, 1997.
15. Hennig IM, Laissue JA, Horisberger U and Reubi JC: Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61: 786-792, 1995.
16. Goodnight J, Mischak H and Mushinski JF: Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv Cancer Res 64: 159-209, 1994.
17. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
18. Cacace AM, Guadagno SN, Krauss RS, Fabbro D and Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095-2104, 1993.
19. Perletti GP, Folini M, Lin HC, Mischak H, Piccinini F and Tashjian A: Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogene 12: 847-854, 1996.
20. Couldwell WT, Uhm JH, Antel JP and Yong VW: Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29: 880-886, 1991.
21. Couldwell WT, Hinton DR and Law RE: Protein kinase C and growth regulation in malignant gliomas. Neurosurgery 35: 1184-1186, 1994.
22. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG and Vertosick FT Jr: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50: 7134-7138, 1990.
23. Baltuch GH, Couldwell WT, Villemure JG and Yong VW: Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33: 495-501, 1993.
24. Begemann M, Kashimawo SA, Choi YA, Kim S, Christiansen KM, Duigou G, Mueller M, Schieren I, Ghosh S, Fabbro D, Lampen NM, Heitjan DF, Schiff PB, Bruce JN and Weinstein B: Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. Clin Cancer Res 2: 1017-1030, 1996.
25. Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Law RE and Apuzzo ML: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705-709, 1994.
26. Furuya KN, Thottassery JV, Schuetz EG, Sharif M and Schuetz JD: Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdrlb) by a novel pathway. J Biol Chem 272: 11518-11525, 1997.
27. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D and Schachtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197, 1993.
28. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH and Law RE: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345: 43-46, 1994.
29. Sun H, Charles CH, Lau LF and Tonks NK: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493, 1993.
30. Alessi DR, Smythe C and Keyse SM: The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopits oocyte extracts. Oncogene 8: 2015-2020, 1993.
31. Sugimoto T, Stewart S and Guan KL: The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. J Biol Chem 272: 29415-29418, 1997.